Skip to content

Perspective Therapeutics CATX Total Operating Expenses

Total Operating Expenses at other companies

CytomX Therapeutics logo
CytomX TherapeuticsCTMX
$29.93M+5.8%
Monopar Therapeutics logo
Monopar TherapeuticsMNPR
$5.23M+62.2%
Immunome logo
ImmunomeIMNM
$59.33M+24.7%
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
$116.31M+23.8%
Precigen logo
PrecigenPGEN
$29.25M+22.2%
Tango Therapeutics logo
Tango TherapeuticsTNGX
$48.77M+1.8%

Other financials

Income statement

See full
Revenue$2.2M+27.3%
Gross profit$738.0K+78.3%
Operating income-$28.3M-29.5%
Net income-$26.2M-44.1%
EPS (diluted)-$0.250.0%

Balance sheet

See full
Cash & equivalents$54.0M+21.5%
Total debt$4.2M+10.9%
Total equity$347.4M+22.1%
Total assets$410.8M+24.7%

Cash flow

See full
Operating cash flow-$31.5M-45.8%
CapEx$6.9M+47.3%
Free cash flow-$38.3M-46.1%

Valuation

See full
Market cap$342.14M+33.2%
Enterprise value$292.34M+35.2%
P/S34.2×+19.6×

Profitability

See full
Gross margin33.1%-7.1pp
Operating margin-292.7%-553pp
Net margin-218.4%-781pp
FCF margin-1,073.3%

Returns & leverage

See full
Return on equity-35.2%+2.3pp
Debt / equity0.0×
Current ratio8.7×-8.3×

Where this comes from

Reported directly by Perspective Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:OperatingExpenses.

The official record: Perspective Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Perspective Therapeutics's total operating expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Perspective Therapeutics's total operating expenses?
Perspective Therapeutics (CATX) reported total operating expenses of $28.36M in Q1 2026.
How has Perspective Therapeutics's total operating expenses changed year-over-year?
Perspective Therapeutics's total operating expenses increased by 27.9% year-over-year, from $22.17M to $28.36M.
What is the long-term trend for Perspective Therapeutics's total operating expenses?
Over 4 years (2021 to 2025), Perspective Therapeutics's total operating expenses has grown at a 91.2% compound annual growth rate (CAGR), from $8.57M to $114.45M.
What does total operating expenses mean?
The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.